SEC Form 4 · accession 0001225208-15-000760
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael P. Phalen
Officer — EVP & President, MedSurg
Period of report
Jan 5, 2015
Accepted (ET)
Jan 6, 2015 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 5, 2015 | S | 10,000 | $13.75 | D | 146,234 | D | |
| Common StockF3 | holding | — | — | — | 2,433 | I | By 401(k) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- F3Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.